Study examines effectiveness of German mammography screening program

NewsGuard 100/100 Score

How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North Rhine-Westphalia and his co-authors in the first study on this subject in Germany, in Deutsches -rzteblatt International (Dtsch Arztebl Int 2012; 109(46): 781-7).

To answer it, the authors have used the interval cancer rate as an indicator. Interval cancers are tumors found more or less by chance between two screenings. In approximately 880 000 women from North Rhine-Westphalia who had taken part in mammography screening for the first time between 2005 and 2008 and had received negative test results, the authors examined whether breast cancer occurred in the following 24 months. It was shown to occur in approximately 2000 women. This corresponds to a rate of 0.23%, a result that is absolutely comparable with similar international studies.

However, the authors also noticed another result in their follow-up research: 40% of all malignant breast tumors of size T2 to T4 (i.e. ranging from at least 2 cm to more than 5 cm) detected in the study participants during the observation period proved to be interval cancers. Further research is needed to explain this phenomenon.

Source: Deutsches Aerzteblatt International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scoping review identifies major social determinants of health that hinder breast cancer screening